Outside Forces
Geopolitics pivots overnight, AI resets every decision, competitors reshape in months. Twelve-month plans expire in twelve weeks.
PreMortem accelerates commercial ambitions by resolving risks before they occur, bridging execution across silos, and driving teams to measurable outcomes.
Let's talkCommercial Truth
Outside forces shift the assumptions under your highest-stakes initiatives faster than teams can absorb. Commercial Truth is the real-time evidence that validates and grounds your initiative, empowering organizations to accelerate, pivot, or stop with conviction.
The Challenge
Geopolitics pivots overnight, AI resets every decision, competitors reshape in months. Twelve-month plans expire in twelve weeks.
Belief holds still while the evidence moves. The assumption hardens, and every forecast built on it inherits the error.
Teams keep executing against assumptions that have already expired, and the initiative loses months the company never gets back.
What We Do
Cross-functional alignment around the highest-leverage commercial drivers that actually decide the outcome, with teams executing together, not in parallel silos.
The decisions that shape the initiative — what to keep, what to build, what to stop — are made on evidence, not opinion.
Attention and capital follow the evidence, with a defensible link between spend and outcome.
Evidence accumulates, decisions sharpen, and the muscle your teams build carries into every initiative after.
Our Track Record
100% partner retention. 3–5x initiative expansion.
We built Bionic, acquired by Accenture Song and now running as Accenture GrowthOS — one of Accenture's most successful acquisitions.
We have worked with 50+ of the Fortune 500, driving more than $10 billion in new revenue, in partnership with the C-suite.
In 2021, Harvard Business Review published a case study on the method behind the GrowthOS and the transformation of the largest CPG company in the world.
PreMortem is the next chapter — focused on driving growth outcomes through AI-native solutions.
Co-Founder & CEO | PreMortem
David builds systems that turn disruption into resilient growth. He is a two-time New York Times bestselling author, including the book New to Big, four-time exited founder, and investor in over 150 startups. Prior to PreMortem, David was the co-founder of Bionic and partnered with the C-suite of Nike, Microsoft, P&G, Citigroup, and 50+ of the Fortune 500.
ConnectCo-Founder & CPO | PreMortem
Lauren is an expert on the intersection of human judgment and AI systems. Previously, she created Accenture Song's first enterprise GenAI product, which subsequently grew into a multi-hundred-million-dollar line of business, and scaled the electric vehicle startup Revel from $0 to $50M on automation-driven operations.
Connect